一个关于开发单克隆抗体生理灵感PKRO模型的教程
Georgi I Kapitanov1, David Flowers1, Diana H Marcantonio1
1Applied BioSimulation, Certara Predictive Technologies, Certara Inc., Concord, Massachusetts, USA.
CPT: pharmacometrics & systems pharmacology
|December 14, 2025
概括
一个新的生理学启发的PKRO (piPKRO) 模型整合了药理动力学 (PK) 和受体占用 (RO) 来开发单克隆抗体 (mAb). 该模型揭示了在作用部位的局部药物耗尽如何影响有效剂量预测.
科学领域:
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
- 计算生物学 计算生物学
背景情况:
- 单克隆抗体 (mAbs) 需要强大的药理动力学 (PK) 和药理动力学 (PD) 建模来开发.
- 传统的模型包括线性mAb排放的2个隔间PK和低剂量非线性PK的目标介导药物排放 (TMDD).
- 同时对 PK,TMDD 和受体占用 (RO) 的建模至关重要,因为目标结合影响 mAb PK.
研究的目的:
- 为针对膜受体的mAbs引入一种由生理学启发的PKRO (piPKRO) 模型.
- 为在行动地点 (SoA) 同时描述 PK (包括 TMDD) 和 RO 提供一个机制框架.
- 提供对mAb分布的直观理解,使用分区系数 (Pdist) 和分布半径 (tdist) 等宏观参数.
主要方法:
- 修改经典的2个隔间PK模型,以纳入生理隔间的体积.
- 药物清除在外血管区和mAb组织度的纳入基于分区系数.
- 与目标位置相关的目标表达和药物结合动态的整合.
主要成果:
- 在案例研究中,piPKRO模型应用于真实世界的数据.
- 分析表明,由于显著的TMDD和药物缓慢分发,SoA可能会出现本地药物枯竭.
- 这种局部耗尽可能导致SoA的RO低于中央区的RO.
结论:
- 该piPKRO模型提供了一个有价值的工具,用于同时PK/RO模拟mAbs.
- 局部药物耗尽可以显著影响SOA的RO,并影响剂量预测.
- 基于生理学信息的建模增强了对mAb排放和疗效的理解.
相关概念视频
Physiological Pharmacokinetic Models: Assumption with Protein Binding
191
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
191
Pharmacokinetic Models: Overview
1.8K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.8K
Model Approaches for Pharmacokinetic Data: Physiological Models
232
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
232
Pharmacokinetic Models: Comparison and Selection Criterion
301
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
301
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
241
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
241
Antibody Structure
65.1K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
65.1K


